SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
SNNA
Delisted
SNNA was delisted on the 16th of December, 2019.
57 hedge funds and large institutions have $36.4M invested in Sienna Biopharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
57
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.06M | |
| 2 | +$2.57M | |
| 3 | +$2.2M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.86M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$1.86M |
Top Sellers
| 1 | -$316K | |
| 2 | -$195K | |
| 3 | -$78K | |
| 4 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$40K |
| 5 |
JPMorgan Chase & Co
New York
|
-$34.6K |